ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

JUVEDERM VOLLURE XC
Aesthetic medicine
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

JUVEDERM VOLLURE XC PP

Generic Name and Formulations:
Hyaluronic acid 17.5mg/mL, 0.3% w/w lidocaine; injectable gel implant.

Company:
Allergan

Therapeutic Use:

Indications for JUVEDERM VOLLURE XC:

Correction of moderate-to-severe facial wrinkles and folds (eg, nasolabial folds).

Adult:

See full labeling. Inject (into mid-to-deep dermis) slowly with least amount of pressure necessary. Wait 3 secs after injecting first small amount before proceeding with rest of the inj. May use supplementary anesthesia during and post-inj. >21yrs: Individualize. Initial treatment: usually 1.7mL per site. Max limit: 20mL/60kg per year. May require touch-up treatments to achieve desired effects.

Children:

Not established.

Contraindications:

History of anaphylaxis or presence of multiple severe allergies. Allergies to Gram (+) bacterial proteins.

Warnings/Precautions:

Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to initiation. Avoid intravascular inj; discontinue immediately if changes in vision, signs of stroke, blanching of skin or unusual pain during or shortly after procedure occurs. Risk of infection. Defer if active inflammatory process or infection is present at specific sites. Use in non-facial wrinkles and folds: not established. Possible risk of an inflammatory reaction at implant site if laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after Juvederm Vollure XC or if product is given before skin has healed completely after such a procedure. Known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders: not studied. Advise patients to avoid strenuous exercise, extensive sun or heat, and alcoholic beverages within first 24hrs. Patients (<22yrs), pregnancy, nursing mothers: not established.

Interactions:

Caution with concomitant immunosuppressants. Increased bruising or bleeding at inj sites with concomitant aspirin, NSAIDs, warfarin.

Pharmacological Class:

Dermal filler.

Adverse Reactions:

Inj site reactions (eg, swelling, tenderness, firmness, bruising, lumps/bumps, redness, pain, discoloration, itching); rare: vision impairment, blindness, cerebral ischemia/hemorrhage, stroke, skin necrosis, facial structure damage.

Generic Availability:

NO

How Supplied:

Single-use syringe—1 (w. needles)

Sign Up for Free e-newsletters